Skip to content

DMT: all studies

Page 15 of 160: studies 141 to 150 of 1,593, newest first. Back to the DMT overview

Research

Vigilance state dissociation induced by 5-MeO DMT in mice

Research Square May 6, 2025 Benjamin J. B. Bréant, José Prius-Mengual, Alexander Andrews et al. preprint

Abstract Psychedelics lead to profound changes in subjective experience and behaviour, which are typically conceptualised in psychological terms rather than corresponding to an altered brain state or a distinct state of arousal. Here, we performed chronic electrophysiological recordings from the neocortex concomitant with pupillometry in freely moving adult male mice following an injection of a...

DOI: 10.21203/rs.3.rs-6377546/v1 (opens in new tab) Psychedelics Consciousness Sleep research Brain activity

5-MeO-DMT

May 1, 2025 Angelica Ukaigwe, Abhishek Chauhan, S. Vinod Kumar

Abstract 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a psychoactive compound found in the parotid gland venom of the Sonoran Desert toad, Incilius alvarius, and certain seeds, leaves, and barks within the Amazonian rainforest. Similar to DMT containing ayahuasca, 5-MeO-DMT has become newly integrated as a spiritual sacrament in certain churches, offering a psychedelic experience to process...

Exploring DMT: Endogenous role and therapeutic potential.

Neuropharmacology May 1, 2025 Jakub Schimmelpfennig, Kamila Jankowiak-Siuda 47 citations

N,N-Dimethyltryptamine (DMT) is a naturally occurring amine and psychedelic compound, found in plants, animals, and humans. While initial studies reported only trace amounts of DMT in mammalian brains, recent findings have identified alternative methylation pathways and DMT levels comparable to classical neurotransmitters in rodent brains, calling for a re-evaluation of its biological role and...

Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.

Neuropsychopharmacology May 1, 2025 Marcelo Falchi-Carvalho, Fernanda Palhano-Fontes, Isabel Wießner et al. 35 citations

Depression affects over 185 million people worldwide, with approximately one-third classified as treatment-resistant depression (TRD). Current treatments, such as oral antidepressants, often take around 3 weeks to become effective, with no immediate anti-suicidal benefits. The field urgently needs innovative therapies that provide rapid relief. Psychedelics like psilocybin and ayahuasca have...

DOI: 10.1038/s41386-025-02091-6 (opens in new tab) Full text (opens in new tab) Mental health Depression treatment Psychedelic medicine Clinical research +1

Safety, Pharmacokinetics, and Pharmacodynamics of a 6-h N,N-Dimethyltryptamine (DMT) Infusion in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Trial.

Clinical and Translational Science May 1, 2025 Katelijne V. van der Heijden, Rob G J A Zuiker, Marije E. Otto et al. 7 citations

The serotonergic psychedelic N,N-dimethyltryptamine (DMT) presumably stimulates neuroplasticity in vitro and in vivo, by which it may exert neuroprotective effects during acute ischemic stroke. Since neuroplasticity has been implicated in the mechanism of action of rehabilitative therapy in stroke recovery, a pharmacological augmentation strategy facilitating neuroplasticity could be...

DOI: 10.1111/cts.70234 (opens in new tab) Full text (opens in new tab) N-dimethyltryptamine N,N‐Dimethyltryptamine Healthy volunteers Intravenousinfusion +10

Network control energy reductions under DMT relate to serotonin receptors, signal diversity, and subjective experience.

Communications Biology April 18, 2025 S Parker Singleton, Christopher Timmermann, Andrea I. Luppi et al. 17 citations

Psychedelics offer a profound window into the human brain through their robust effects on perception, subjective experience, and brain activity patterns. The serotonergic psychedelic N,N-dimethyltryptamine (DMT) induces a profoundly immersive altered state of consciousness lasting under 20 min, allowing the entire experience to be captured during a single functional magnetic resonance imaging...

Dynamic medial parietal and hippocampal deactivations under DMT relate to sympathetic output and altered sense of time, space, and the self

Imaging Neuroscience April 16, 2025 Lorenzo Pasquini, Alexander J. Simon, Courtney L. Gallen et al. 4 citations

Abstract N,N-Dimethyltryptamine (DMT) is a serotonergic psychedelic, known to rapidly induce short-lasting alterations in conscious experience, characterized by a profound and immersive sense of physical transcendence alongside rich and vivid auditory distortions and visual imagery. Multimodal neuroimaging data paired with dynamic analysis techniques offer a valuable approach for identifying...

A Toad Less Traveled: Should 5-MeO-DMT Have a Role in Treating Depression?

Psychedelic Medicine April 14, 2025 Caroline Hayes

As the therapeutic potential of psychedelics is becoming more established, a wider range of compounds are beginning to be investigated for their antidepressant properties. 5-Methoxy- N , N -dimethyltryptamine (5-MeO-DMT) is one such example; its unusual properties may make it a more cost-effective and practical choice for health care providers. However, the same distinctive features may mean...

The evolution of N, N-Dimethyltryptamine: from metabolic pathways to brain connectivity.

Psychopharmacology April 11, 2025 Swanti Gupta, Raj K Bhatnagar, Dinesh Gupta et al. 27 citations

N, N-Dimethyltryptamine (DMT), a potent serotonergic psychedelic, bridges ancient wisdom and modern science. The mechanisms underlying its powerful psychedelic effects and out-of-body experiences continue to intrigue scientists. The functional role of DMT remains ambiguous. This paper explores the endogenous presence of DMT in the human body and its diverse neuroregulatory functions, which...

DOI: 10.1007/s00213-025-06777-z (opens in new tab) Full text (opens in new tab) Cognition Endogenous DMT Exogenous DMT Global neural network +4

N, N-dimethyltryptamine (DMT) in rodent brain: Concentrations, distribution, and recent pharmacological data.

Progress in Neuro-Psychopharmacology and Biological Psychiatry March 20, 2025 Steven A. Barker 3 citations

Renewed interest in the clinical use of psychedelic drugs acknowledges their therapeutic effectiveness. It has also provided a changing frame of reference for older psychedelic drug study data, especially regarding concentrations of N, N-dimethyltryptamine (DMT) reported in rodent brains and recent discoveries in DMT receptor interactions in rat brain neurons and select brain areas. The mode of...